Exercise Training Attenuates Cirrhotic Cardiomyopathy

Area of Science:

• Cardiology
• Hepatology
• Exercise Physiology

Background:

• Liver cirrhosis is linked to cardiac dysfunction, a condition known as cirrhotic cardiomyopathy.
• The factors influencing cirrhotic cardiomyopathy are not well understood, impacting patient prognosis.
• Investigating interventions like exercise training is crucial for managing chronic liver disease.

Purpose of the Study:

• To determine if exercise training can mitigate liver damage induced by thioacetamide (TAA).
• To assess the potential of exercise training in preventing cardiac dysfunction associated with liver cirrhosis.
• To explore the effects of exercise on the phenotype of cirrhotic cardiomyopathy.

Main Methods:

• Wistar rats were assigned to control, thioacetamide (TAA) exposure, or TAA exposure plus exercise training groups.
• Liver injury was assessed by measuring liver weight, serum enzyme levels (ALT, AST), and histological examination.
• Cardiac function was evaluated by assessing cardiac hypertrophy, and diastolic and systolic performance.

Main Results:

• Thioacetamide administration led to significant liver damage, including increased liver enzymes, nodule formation, fibrosis, inflammation, and necrosis.
• Rats treated with TAA exhibited cardiac remodeling, diastolic dysfunction, and systolic impairment.
• Exercise training in TAA-treated rats significantly reduced liver injury markers and attenuated cardiac remodeling and diastolic dysfunction, while preventing systolic impairment.

Conclusions:

• Exercise training demonstrates a protective effect against thioacetamide-induced liver injury in rats.
• Exercise training can effectively mitigate cardiac remodeling and diastolic dysfunction in the context of liver cirrhosis.
• These findings suggest that exercise training is a promising therapeutic strategy for preventing and managing cirrhotic cardiomyopathy.